Chandrasena Gillian 4

What Happened Gillian Chandrasena, SVP and Chief Human Resources Officer of MiniMed Group, received two derivative awards on March 9, 2026 totaling 70,077 units (6,945 and 63,132). Both were recorded as grants/awards at $0.00 per share (no cash paid); they are contingent performance-based restricted stock units (RSUs) and do not represent immediately owned tradable shares.

Key Details

• Transaction date: 2026-03-09 — two awards: 6,945 RSUs and 63,132 RSUs; price reported $0.00 (award/grant, code A).
• Total awarded: 70,077 derivative units. Immediate reported value: $0.00.
• Shares owned after transaction: not stated in the filing.
• Vesting/conditions (footnotes):
  • F1/F2 — The performance-based RSUs are each a contingent right to receive one share and vest on March 9, 2027 (or the "Divestment Date"), only if MMED closing price meets or exceeds $32.05 as of the Divestment Date.
  • F3 — Separate award language indicates an option-like award that vests 33% on each of March 9, 2028 and 2029, and 34% on March 9, 2030.
• Filing timeliness: Form 4 was filed on 2026-03-11 for the 2026-03-09 transaction (filed within the standard two-business-day window).

Context These are contingent, performance-based RSU grants — a promise to deliver shares only if vesting conditions (time and a $32.05 price target tied to a defined Divestment Date) are met. Because they carry $0 immediate value and are not sales or open-market purchases, they do not reflect immediate buying or selling activity and should be viewed as compensation-related awards rather than a direct signal of insider buying or selling.